Dr Michele Orini shares how machine learning can help identify critical VT ablation targets for a safer, data-driven ...
Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...
Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.
Researchers at RIT are developing non-invasive technology that will better assess cardiac tissue response to thermal energy, a common therapy approach for both cancer and cardiac arrhythmia treatments ...
BOSTON -- For persistent atrial fibrillation (Afib), adding artificial intelligence guidance for ablation site selection improved success, the TAILORED trial showed. Freedom from Afib after one ...
Millions of people around the world are diagnosed with heart failure and atrial fibrillation every year. In the weakened state, the heart is unable to pump enough oxygenated blood throughout the body.
The knowledge that recovering Covid-19 patients face an increased risk of cardiac arrhythmia(Opens in a new window) complications, is one factor contributing to the ...
Company’s proprietary system used to treat initial five patients in first-in-human feasibility study for patients with atrial fibrillation HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback